文献速递腹部技术与安全MR

胰腺导管腺癌S100A4过表达:全肿瘤MRI纹理分析影像生物标志物

S100A4 overexpression in pancreatic ductal adenocarcinoma: imaging biomarkers from whole-tumor evaluation with MRI and texture analysis.
PubMed 文献 · Abdom Radiol (NY) · 2020-08-01

回顾性纳入60例病理确诊胰腺导管腺癌患者,术前行1.5T腹部增强MRI并行全肿瘤纹理分析,定量评估S100A4表达。单因素及多因素分析显示,远端胰管扩张、T1WI第10百分位及延迟期与门静脉期强化率差值可独立预测S100A4过表达,联合模型AUC为0.877,敏感度80.6%、特异度75.0%。

要点

  • 远端胰管扩张、T1WI第10百分位、延迟期与门静脉期强化率差值可独立预测S100A4过表达。
  • 联合模型AUC 0.877,敏感度80.6%,特异度75.0%。
  • 36/60例(60.0%)肿瘤呈S100A4过表达,24例(40.0%)为阴性。

关键影像表现/征象

  • 远端胰管扩张、T1WI第10百分位及延迟期与门静脉期强化率差值被确定为独立预测S100A4过表达的影像指标(p分别为0.009、0.012和0.044)。
  • 上述三个指标的比值比(OR)分别为0.102、0.139和4.645。
  • 三个指标各自的ROC曲线下面积(AUC)分别为0.715、0.707和0.691。

诊断标准与关键数值

  • 联合模型预测S100A4过表达的AUC为0.877,敏感度80.6%,特异度75.0%。
  • 36例(60.0%)肿瘤为S100A4过表达,24例(40.0%)为S100A4过表达阴性。

临床应用与阅片要点

  • 阅片时可关注远端胰管扩张、T1WI第10百分位及延迟期与门静脉期强化率差值,作为预测S100A4过表达的影像生物标志物。
  • 联合上述三项指标的模型AUC为0.877,敏感度80.6%、特异度75.0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the relationship between imaging findings and S100A4 overexpression in pancreatic ductal adenocarcinoma (PDAC) and to determine imaging biomarkers of S100A4 overexpression from whole-tumor evaluation with MRI and texture analysis.

METHODS: A total of 60 patients with pathologically confirmed PDAC were included in the study. All patients underwent preoperative abdominal contrast-enhanced MRI examination with Magnetom Aera (Siemens Healthcare, Germany, 1.5 T) at our institute. Whole-tumor evaluation including texture analysis was performed. Sections of specimens were reviewed, and the S100A4 expression status was quantitatively evaluated. Univariate and multivariate logistic regression analyses were conducted to find imaging biomarkers that could predict S100A4 overexpression.

RESULTS: Twenty-four tumors (40.0%) had negative results for S100A4 overexpression, and 36 tumors (60.0%) exhibited overexpression. After univariate and multivariate analysis, distal pancreatic duct dilatation, T1WI_10th percentile and the enhancement rate difference between delayed phase (DP) and portal venous phase (PVP) were identified to predict S100A4 overexpression in PDAC independently (p = 0.009, 0.012 and 0.044), with odds ratios (ORs) of 0.102, 0.139 and 4.645, respectively. The area under the ROC curve (AUC) values were 0.715, 0.707 and 0.691. The AUC value of the proposed model was 0.877 with a sensitivity of 80.6% and specificity of 75.0%.

CONCLUSION: A model including distal pancreatic duct dilatation, T1WI_10th percentile and the enhancement rate difference between the DP and PVP could predict S100A4 overexpression in PDAC as imaging biomarkers.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Liang L, Luo R, Ding Y, et al. S100A4 overexpression in pancreatic ductal adenocarcinoma: imaging biomarkers from whole-tumor evaluation with MRI and texture analysis. Abdom Radiol (NY). 2020. PMID: 32740861. doi:10.1007/s00261-020-02676-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。